智通财经APP讯,莱美药业(300006.SZ)公告,公司董事会提请股东大会授权董事会全权办理以简易程序向特定对象发行股票的相关事宜,授权期限为2022年年度股东大会通过之日起至2023年年度股东大会召开之日止,拟向不超过35名的特定对象发行股票,发行价格不低于定价基准日前20个交易日股票交易均价的80%,本次发行股票募集资金总额不超过3亿元且不超过最近一年末净资产的20%。
莱美药业(300006.SZ)拟简易程序定增募资不超3亿元
Laimei Pharmaceutical (300006.SZ) plans a simplified procedure to raise no more than 300 million yuan
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.